Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
Tiziana Life Sciences CEO Ivor Elrifi purchased 667,000 common shares on NASDAQ at a price of $1.00 per share. This transaction increases Elrifi's total beneficial ownership to 4,472,261 common shares.
Key figures
- Purchase Price
- 1
- Total Holdings
- 4472261
- Shares Purchased
- 667000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.